Skip to main content
Erschienen in: International Urology and Nephrology 8/2023

10.06.2023 | Urology - Original Paper

Sufentanil inhibits Pin1 to attenuate renal tubular epithelial cell ischemia–reperfusion injury by activating the PI3K/AKT/FOXO1 pathway

verfasst von: Chunhui Liu, Qingdong Wang, Li Niu

Erschienen in: International Urology and Nephrology | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Renal ischemia–reperfusion injury (RIRI) has become a great concern in clinical practice with high morbidity and mortality rates. Sufentanil has protective effects on IRI-induced organ injury. Herein, the effects of sufentanil on RIRI were investigated.

Methods

RIRI cell model was established by hypoxia/reperfusion (H/R) stimulation. The mRNA and protein expressions were assessed using qRT-PCR and western blot. TMCK-1 cell viability and apoptosis were assessed using MTT assay and flow cytometry, respectively. The mitochondrial membrane potential and ROS level were detected by JC-1 mitochondrial membrane potential fluorescent probe and DCFH-DA fluorescent probe, respectively. LDH, SOD, CAT, GSH and MDA levels were determined by the kits. The interaction between FOXO1 and Pin1 promoter was analyzed using dual luciferase reporter gene and ChIP assays.

Results

Our results revealed that sufentanil treatment attenuated H/R-induced cell apoptosis, mitochondrial membrane potential (MMP) dysfunction, oxidative stress, inflammation and activated PI3K/AKT/FOXO1 associated proteins, while these effects were reversed by PI3K inhibitor, suggesting that sufentanil attenuated RIRI via activating the PI3K/AKT/FOXO1 signaling pathway. We subsequently found that FOXO1 transcriptionally activated Pin1 in TCMK-1 cells. Pin1 inhibition ameliorated H/R-induced TCMK-1 cell apoptosis, oxidative stress and inflammation. In addition, as expected, the biological effects of sufentanil on H/R-treated TMCK-1 cells were abrogated by Pin1 overexpression.

Conclusion

Sufentanil reduced Pin1 expression through activation of the PI3K/AKT/FOXO1 signaling to suppress cell apoptosis, oxidative stress and inflammation in renal tubular epithelial cells during RIRI development.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Marston A (1985) Ischaemia. Clin Gastroenterol 14(4):847–862PubMed Marston A (1985) Ischaemia. Clin Gastroenterol 14(4):847–862PubMed
2.
Zurück zum Zitat Bonventre JV, Weinberg JM (2003) Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14(8):2199–2210PubMedCrossRef Bonventre JV, Weinberg JM (2003) Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 14(8):2199–2210PubMedCrossRef
3.
Zurück zum Zitat Devarajan P (2006) Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17(6):1503–1520PubMedCrossRef Devarajan P (2006) Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17(6):1503–1520PubMedCrossRef
4.
Zurück zum Zitat Smith SF, Hosgood SA, Nicholson ML (2019) Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells. Kidney Int 95(1):50–56PubMedCrossRef Smith SF, Hosgood SA, Nicholson ML (2019) Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells. Kidney Int 95(1):50–56PubMedCrossRef
5.
Zurück zum Zitat Dong Y, Yin J, Chen T, Wen J, Zhang Q, Li X et al (2021) Dl-3-n-butylphthalide pretreatment attenuates renal ischemia/reperfusion injury. Biochem Biophys Res Commun 557:166–173PubMedCrossRef Dong Y, Yin J, Chen T, Wen J, Zhang Q, Li X et al (2021) Dl-3-n-butylphthalide pretreatment attenuates renal ischemia/reperfusion injury. Biochem Biophys Res Commun 557:166–173PubMedCrossRef
6.
Zurück zum Zitat Case J, Khan S, Khalid R, Khan A (2013) Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Prac 2013:479730 Case J, Khan S, Khalid R, Khan A (2013) Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Prac 2013:479730
7.
Zurück zum Zitat Hosszu A, Fekete A, Szabo AJ (2020) Sex differences in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 319(2):F149–F154PubMedCrossRef Hosszu A, Fekete A, Szabo AJ (2020) Sex differences in renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 319(2):F149–F154PubMedCrossRef
8.
Zurück zum Zitat Zhang J, Han C, Dai H, Hou J, Dong Y, Cui X et al (2016) Hypoxia-Inducible factor-2α limits natural killer T cell cytotoxicity in renal ischemia/reperfusion injury. J Am Soc Nephrol 27(1):92–106PubMedCrossRef Zhang J, Han C, Dai H, Hou J, Dong Y, Cui X et al (2016) Hypoxia-Inducible factor-2α limits natural killer T cell cytotoxicity in renal ischemia/reperfusion injury. J Am Soc Nephrol 27(1):92–106PubMedCrossRef
9.
Zurück zum Zitat Rabb H, Griffin MD, McKay DB, Swaminathan S, Pickkers P, Rosner MH et al (2016) Inflammation in AKI: current understanding, key questions, and knowledge gaps. J Am Soc Nephrol 27(2):371–379PubMedCrossRef Rabb H, Griffin MD, McKay DB, Swaminathan S, Pickkers P, Rosner MH et al (2016) Inflammation in AKI: current understanding, key questions, and knowledge gaps. J Am Soc Nephrol 27(2):371–379PubMedCrossRef
11.
Zurück zum Zitat Lango R, Mroziński P (2010) Clinical importance of anaesthetic preconditioning. Anestezjol Intens Ter 42(4):206–212PubMed Lango R, Mroziński P (2010) Clinical importance of anaesthetic preconditioning. Anestezjol Intens Ter 42(4):206–212PubMed
12.
Zurück zum Zitat Swyers T, Redford D, Larson DF (2014) Volatile anesthetic-induced preconditioning. Perfusion 29(1):10–15PubMedCrossRef Swyers T, Redford D, Larson DF (2014) Volatile anesthetic-induced preconditioning. Perfusion 29(1):10–15PubMedCrossRef
13.
Zurück zum Zitat Zhao L, Li Y (2020) Application of dexmedetomidine combined with sufentanil in colon cancer resection and its effect on immune and coagulation function of patients. Oncol Lett 20(2):1288–1294PubMedPubMedCentralCrossRef Zhao L, Li Y (2020) Application of dexmedetomidine combined with sufentanil in colon cancer resection and its effect on immune and coagulation function of patients. Oncol Lett 20(2):1288–1294PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Zhou H, Zhu ZH, Liu Y, Liu YY (2020) Effects of midazolam combined with sufentanil on injury and expression of HMGB1 and NF-κB in rats with pancreatitis. Eur Rev Med Pharmacol Sci 24(4):2102–2109PubMed Zhou H, Zhu ZH, Liu Y, Liu YY (2020) Effects of midazolam combined with sufentanil on injury and expression of HMGB1 and NF-κB in rats with pancreatitis. Eur Rev Med Pharmacol Sci 24(4):2102–2109PubMed
15.
Zurück zum Zitat Wang XH, Zeng JF, Lin C, Chen SB (2015) Effects of morphine and sufentanil preconditioning against myocardial ischemic-reperfusion injury in rabbits. Int J Clin Exp Med 8(9):15692–15699PubMedPubMedCentral Wang XH, Zeng JF, Lin C, Chen SB (2015) Effects of morphine and sufentanil preconditioning against myocardial ischemic-reperfusion injury in rabbits. Int J Clin Exp Med 8(9):15692–15699PubMedPubMedCentral
16.
Zurück zum Zitat Zuo Y, Cheng X, Gu E, Liu X, Zhang L, Cao Y (2014) Effect of aortic root infusion of Sufentanil on ischemia-reperfusion injury in patients undergoing mitral valve replacement. J Cardiothorac Vasc Anesth 28(6):1474–1478PubMedCrossRef Zuo Y, Cheng X, Gu E, Liu X, Zhang L, Cao Y (2014) Effect of aortic root infusion of Sufentanil on ischemia-reperfusion injury in patients undergoing mitral valve replacement. J Cardiothorac Vasc Anesth 28(6):1474–1478PubMedCrossRef
17.
Zurück zum Zitat Lian YH, Fang J, Zhou HD, Jiang HF, Xie KJ (2019) Sufentanil preconditioning protects against hepatic ischemia-reperfusion injury by suppressing inflammation. Med Sci Monit 25:2265–2273PubMedPubMedCentralCrossRef Lian YH, Fang J, Zhou HD, Jiang HF, Xie KJ (2019) Sufentanil preconditioning protects against hepatic ischemia-reperfusion injury by suppressing inflammation. Med Sci Monit 25:2265–2273PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Wu Q, Shang Y, Bai Y, Wu Y, Wang H, Shen T (2021) Sufentanil preconditioning protects against myocardial ischemia/reperfusion injury via miR-125a/DRAM2 axis. Cell cycle (Georgetown, Tex) 20(4):383–391PubMedCrossRef Wu Q, Shang Y, Bai Y, Wu Y, Wang H, Shen T (2021) Sufentanil preconditioning protects against myocardial ischemia/reperfusion injury via miR-125a/DRAM2 axis. Cell cycle (Georgetown, Tex) 20(4):383–391PubMedCrossRef
19.
Zurück zum Zitat Chen Y, Li Z, Li H, Su W, Xie Y, Pan Y et al (2020) Apremilast regulates the Teff/Treg balance to ameliorate uveitis via PI3K/AKT/FoxO1 signaling pathway. Front Immunol 11:581673PubMedPubMedCentralCrossRef Chen Y, Li Z, Li H, Su W, Xie Y, Pan Y et al (2020) Apremilast regulates the Teff/Treg balance to ameliorate uveitis via PI3K/AKT/FoxO1 signaling pathway. Front Immunol 11:581673PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Villegas SN, Gombos R, García-López L, Gutiérrez-Pérez I, García-Castillo J, Vallejo DM et al (2018) PI3K/Akt cooperates with oncogenic notch by inducing nitric oxide-dependent inflammation. Cell Rep 22(10):2541–2549PubMedCrossRef Villegas SN, Gombos R, García-López L, Gutiérrez-Pérez I, García-Castillo J, Vallejo DM et al (2018) PI3K/Akt cooperates with oncogenic notch by inducing nitric oxide-dependent inflammation. Cell Rep 22(10):2541–2549PubMedCrossRef
22.
Zurück zum Zitat Xu S, Wang J, Zhong J, Shao M, Jiang J, Song J et al (2021) CD73 alleviates GSDMD-mediated microglia pyroptosis in spinal cord injury through PI3K/AKT/Foxo1 signaling. Clin Transl Med 11(1):e269PubMedCrossRef Xu S, Wang J, Zhong J, Shao M, Jiang J, Song J et al (2021) CD73 alleviates GSDMD-mediated microglia pyroptosis in spinal cord injury through PI3K/AKT/Foxo1 signaling. Clin Transl Med 11(1):e269PubMedCrossRef
23.
Zurück zum Zitat Link W (2019) Introduction to FOXO biology. Methods Mol Biol (Clifton, NJ) 1890:1–9CrossRef Link W (2019) Introduction to FOXO biology. Methods Mol Biol (Clifton, NJ) 1890:1–9CrossRef
24.
Zurück zum Zitat Chen E, Chen C, Niu Z, Gan L, Wang Q, Li M et al (2020) Poly(I:C) preconditioning protects the heart against myocardial ischemia/reperfusion injury through TLR3/PI3K/Akt-dependent pathway. Signal Transduct Target Ther 5(1):216PubMedPubMedCentralCrossRef Chen E, Chen C, Niu Z, Gan L, Wang Q, Li M et al (2020) Poly(I:C) preconditioning protects the heart against myocardial ischemia/reperfusion injury through TLR3/PI3K/Akt-dependent pathway. Signal Transduct Target Ther 5(1):216PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Wang D, Wang Y, Zou X, Shi Y, Liu Q, Huyan T et al (2020) FOXO1 inhibition prevents renal ischemia-reperfusion injury via cAMP-response element binding protein/PPAR-γ coactivator-1α-mediated mitochondrial biogenesis. Br J Pharmacol 177(2):432–448PubMedCrossRef Wang D, Wang Y, Zou X, Shi Y, Liu Q, Huyan T et al (2020) FOXO1 inhibition prevents renal ischemia-reperfusion injury via cAMP-response element binding protein/PPAR-γ coactivator-1α-mediated mitochondrial biogenesis. Br J Pharmacol 177(2):432–448PubMedCrossRef
26.
Zurück zum Zitat Wang L, Ge C, Zhang X (2022) Sufentanil ameliorates oxygen-glucose deprivation/reoxygenation-induced endothelial barrier dysfunction in HCMECs via the PI3K/Akt signaling pathway. Exp Ther Med 24(1):437PubMedPubMedCentralCrossRef Wang L, Ge C, Zhang X (2022) Sufentanil ameliorates oxygen-glucose deprivation/reoxygenation-induced endothelial barrier dysfunction in HCMECs via the PI3K/Akt signaling pathway. Exp Ther Med 24(1):437PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Lu KP, Zhou XZ (2007) The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol 8(11):904–916PubMedCrossRef Lu KP, Zhou XZ (2007) The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol 8(11):904–916PubMedCrossRef
28.
Zurück zum Zitat Balaganapathy P, Baik SH, Mallilankaraman K, Sobey CG, Jo DG, Arumugam TV (2018) Interplay between Notch and p53 promotes neuronal cell death in ischemic stroke. J Cereb Blood Flow Metab 38(10):1781–1795PubMedCrossRef Balaganapathy P, Baik SH, Mallilankaraman K, Sobey CG, Jo DG, Arumugam TV (2018) Interplay between Notch and p53 promotes neuronal cell death in ischemic stroke. J Cereb Blood Flow Metab 38(10):1781–1795PubMedCrossRef
29.
Zurück zum Zitat Zhao X, Wang D, Wan S, Liu X, Wang W, Wang L (2021) The suppression of Pin1-alleviated oxidative stress through the p38 MAPK pathway in ischemia- and reperfusion-induced acute kidney injury. Oxid Med Cell Longev 2021:1313847PubMedPubMedCentralCrossRef Zhao X, Wang D, Wan S, Liu X, Wang W, Wang L (2021) The suppression of Pin1-alleviated oxidative stress through the p38 MAPK pathway in ischemia- and reperfusion-induced acute kidney injury. Oxid Med Cell Longev 2021:1313847PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Chang HM, Berde CB, Holz GG, Steward GF, Kream RM (1989) Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions. Anesthesiology 70(4):672–677PubMedCrossRef Chang HM, Berde CB, Holz GG, Steward GF, Kream RM (1989) Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions. Anesthesiology 70(4):672–677PubMedCrossRef
31.
Zurück zum Zitat Feng B, Dong Z, Wang Y, Yan G, Yang E, Cheng H et al (2021) Li-ESWT treatment reduces inflammation, oxidative stress, and pain via the PI3K/AKT/FOXO1 pathway in autoimmune prostatitis rat models. Andrology 9(5):1593–1602PubMedCrossRef Feng B, Dong Z, Wang Y, Yan G, Yang E, Cheng H et al (2021) Li-ESWT treatment reduces inflammation, oxidative stress, and pain via the PI3K/AKT/FOXO1 pathway in autoimmune prostatitis rat models. Andrology 9(5):1593–1602PubMedCrossRef
32.
Zurück zum Zitat Ahonen J, Olkkola KT, Hynynen M, Seppälä T, Ikävalko H, Remmerie B et al (2000) Comparison of alfentanil, fentanyl and sufentanil for total intravenous anaesthesia with propofol in patients undergoing coronary artery bypass surgery. Br J Anaesth 85(4):533–540PubMedCrossRef Ahonen J, Olkkola KT, Hynynen M, Seppälä T, Ikävalko H, Remmerie B et al (2000) Comparison of alfentanil, fentanyl and sufentanil for total intravenous anaesthesia with propofol in patients undergoing coronary artery bypass surgery. Br J Anaesth 85(4):533–540PubMedCrossRef
33.
34.
Zurück zum Zitat Guerra-Mora JR, Perales-Caldera E, Aguilar-León D, Nava-Sanchez C, Díaz-Cruz A, Díaz-Martínez NE et al (2017) Effects of sildenafil and tadalafil on edema and reactive oxygen species production in an experimental model of lung ischemia-reperfusion injury. Transpl Proc 49(6):1461–1466CrossRef Guerra-Mora JR, Perales-Caldera E, Aguilar-León D, Nava-Sanchez C, Díaz-Cruz A, Díaz-Martínez NE et al (2017) Effects of sildenafil and tadalafil on edema and reactive oxygen species production in an experimental model of lung ischemia-reperfusion injury. Transpl Proc 49(6):1461–1466CrossRef
35.
Zurück zum Zitat Ishimoto Y, Tanaka T, Yoshida Y, Inagi R (2018) Physiological and pathophysiological role of reactive oxygen species and reactive nitrogen species in the kidney. Clin Exp Pharmacol Physiol 45(11):1097–1105PubMedPubMedCentralCrossRef Ishimoto Y, Tanaka T, Yoshida Y, Inagi R (2018) Physiological and pathophysiological role of reactive oxygen species and reactive nitrogen species in the kidney. Clin Exp Pharmacol Physiol 45(11):1097–1105PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Shan Y, Chen D, Hu B, Xu G, Li W, Jin Y et al (2021) Allicin ameliorates renal ischemia/reperfusion injury via inhibition of oxidative stress and inflammation in rats. Biomed Pharmacother Biomed Pharmacother 142:112077PubMedCrossRef Shan Y, Chen D, Hu B, Xu G, Li W, Jin Y et al (2021) Allicin ameliorates renal ischemia/reperfusion injury via inhibition of oxidative stress and inflammation in rats. Biomed Pharmacother Biomed Pharmacother 142:112077PubMedCrossRef
37.
Zurück zum Zitat Theofilatos D, Fotakis P, Valanti E, Sanoudou D, Zannis V, Kardassis D (2018) HDL-apoA-I induces the expression of angiopoietin like 4 (ANGPTL4) in endothelial cells via a PI3K/AKT/FOXO1 signaling pathway. Metab Clin Exp 87:36–47PubMedCrossRef Theofilatos D, Fotakis P, Valanti E, Sanoudou D, Zannis V, Kardassis D (2018) HDL-apoA-I induces the expression of angiopoietin like 4 (ANGPTL4) in endothelial cells via a PI3K/AKT/FOXO1 signaling pathway. Metab Clin Exp 87:36–47PubMedCrossRef
38.
Zurück zum Zitat He F, Zhang N, Lv Y, Sun W, Chen H (2019) Low-dose lipopolysaccharide inhibits neuronal apoptosis induced by cerebral ischemia/reperfusion injury via the PI3K/Akt/FoxO1 signaling pathway in rats. Mol Med Rep 19(3):1443–1452PubMedPubMedCentral He F, Zhang N, Lv Y, Sun W, Chen H (2019) Low-dose lipopolysaccharide inhibits neuronal apoptosis induced by cerebral ischemia/reperfusion injury via the PI3K/Akt/FoxO1 signaling pathway in rats. Mol Med Rep 19(3):1443–1452PubMedPubMedCentral
39.
Zurück zum Zitat Zhu J, Xue JC, Law PY, Claude PA, Luo LY, Yin J et al (1996) The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor. FEBS Lett 384(2):198–202PubMedCrossRef Zhu J, Xue JC, Law PY, Claude PA, Luo LY, Yin J et al (1996) The region in the mu opioid receptor conferring selectivity for sufentanil over the delta receptor is different from that over the kappa receptor. FEBS Lett 384(2):198–202PubMedCrossRef
40.
Zurück zum Zitat Zou S, Sun H, Peng Y, Liang C, Zheng C, Wang L et al (2023) Mu-opioid receptor alleviated ferroptosis in hepatic ischemia-reperfusion injury via the HIF-1α/KCNQ1OT1 axis. Am J Physiol Cell Physiol 324(4):C927–C940PubMedCrossRef Zou S, Sun H, Peng Y, Liang C, Zheng C, Wang L et al (2023) Mu-opioid receptor alleviated ferroptosis in hepatic ischemia-reperfusion injury via the HIF-1α/KCNQ1OT1 axis. Am J Physiol Cell Physiol 324(4):C927–C940PubMedCrossRef
41.
Zurück zum Zitat Ji S, Wang L (2019) μ-Opioid receptor signalling via PI3K/Akt pathway ameliorates lipopolysaccharide-induced acute respiratory distress syndrome. Exp Physiol 104(10):1555–1561PubMedCrossRef Ji S, Wang L (2019) μ-Opioid receptor signalling via PI3K/Akt pathway ameliorates lipopolysaccharide-induced acute respiratory distress syndrome. Exp Physiol 104(10):1555–1561PubMedCrossRef
42.
Zurück zum Zitat Kuboki S, Sakai N, Clarke C, Schuster R, Blanchard J, Edwards MJ et al (2009) The peptidyl-prolyl isomerase, Pin1, facilitates NF-kappaB binding in hepatocytes and protects against hepatic ischemia/reperfusion injury. J Hepatol 51(2):296–306PubMedPubMedCentralCrossRef Kuboki S, Sakai N, Clarke C, Schuster R, Blanchard J, Edwards MJ et al (2009) The peptidyl-prolyl isomerase, Pin1, facilitates NF-kappaB binding in hepatocytes and protects against hepatic ischemia/reperfusion injury. J Hepatol 51(2):296–306PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Chuang HH, Zhen YY, Tsai YC, Chuang CH, Huang MS, Hsiao M et al (2021) Targeting Pin1 for modulation of cell motility and cancer therapy. Biomedicines 9(4):359PubMedPubMedCentralCrossRef Chuang HH, Zhen YY, Tsai YC, Chuang CH, Huang MS, Hsiao M et al (2021) Targeting Pin1 for modulation of cell motility and cancer therapy. Biomedicines 9(4):359PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Penela P, Inserte J, Ramos P, Rodriguez-Sinovas A, Garcia-Dorado D, Mayor F Jr (2019) Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion. EBioMedicine 48:605–618PubMedPubMedCentralCrossRef Penela P, Inserte J, Ramos P, Rodriguez-Sinovas A, Garcia-Dorado D, Mayor F Jr (2019) Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion. EBioMedicine 48:605–618PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Baik SH, Fane M, Park JH, Cheng YL, Yang-Wei Fann D, Yun UJ et al (2015) Pin1 promotes neuronal death in stroke by stabilizing Notch intracellular domain. Ann Neurol 77(3):504–516PubMedCrossRef Baik SH, Fane M, Park JH, Cheng YL, Yang-Wei Fann D, Yun UJ et al (2015) Pin1 promotes neuronal death in stroke by stabilizing Notch intracellular domain. Ann Neurol 77(3):504–516PubMedCrossRef
Metadaten
Titel
Sufentanil inhibits Pin1 to attenuate renal tubular epithelial cell ischemia–reperfusion injury by activating the PI3K/AKT/FOXO1 pathway
verfasst von
Chunhui Liu
Qingdong Wang
Li Niu
Publikationsdatum
10.06.2023
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 8/2023
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-023-03651-9

Weitere Artikel der Ausgabe 8/2023

International Urology and Nephrology 8/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.